Hans-Peter Hammes Selected Research

Body Weight (Weight, Body)

12/2021	Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy.
1/2014	Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration.
1/2011	Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy.
1/2011	Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy.
4/2009	SGK1-sensitive renal tubular glucose reabsorption in diabetes.
4/2006	Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans-Peter Hammes Research Topics

Disease

33	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 03/2002
26	Hyperglycemia 01/2023 - 03/2003
8	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 08/2005
6	Body Weight (Weight, Body) 12/2021 - 04/2006
6	Inflammation (Inflammations) 01/2021 - 08/2004
5	Diabetes Complications 01/2022 - 03/2003
5	Obesity 01/2021 - 11/2012
5	Macular Edema 12/2018 - 07/2011
5	Retinal Neovascularization 04/2017 - 08/2004
5	Hypoxia (Hypoxemia) 07/2009 - 08/2004
4	Fibrosis (Cirrhosis) 11/2023 - 10/2017
4	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2006
4	Diabetes Mellitus 12/2021 - 04/2009
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 12/2019 - 10/2002
3	Blindness (Hysterical Blindness) 04/2023 - 03/2002
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2021 - 10/2006
3	Insulin Resistance 01/2021 - 01/2014
3	Retinal Degeneration 01/2021 - 10/2006
3	Neoplasms (Cancer) 02/2006 - 02/2004
2	Osteoarthritis 01/2022 - 12/2021
2	Microaneurysm 01/2020 - 10/2002
2	Hyperoxia 12/2019 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 01/2017
2	Ganglion Cysts (Ganglion) 01/2019 - 01/2016
2	Ischemia 12/2018 - 04/2017
2	Cysts 01/2018 - 10/2006
2	Norrie disease 01/2017 - 09/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2016 - 01/2014
2	Morbid Obesity 04/2016 - 09/2013
2	Vascular Diseases (Vascular Disease) 02/2016 - 01/2009
2	Albuminuria 01/2012 - 05/2011
1	Weight Gain 11/2023
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	Chronic Renal Insufficiency 04/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	War-Related Injuries 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Ciliopathies 10/2021
1	Disease Progression 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Iron Overload 01/2021

Drug/Important Bio-Agent (IBA)

41	Retinaldehyde (Retinal)IBA 04/2023 - 08/2004
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
9	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 04/2009
8	Advanced Glycation End ProductsIBA 01/2022 - 03/2002
7	Pyruvaldehyde (Methylglyoxal)IBA 12/2021 - 01/2006
7	Angiopoietin-2IBA 10/2020 - 04/2004
6	HexosaminesIBA 01/2023 - 03/2003
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 03/2002
4	Protein Kinase CIBA 10/2019 - 03/2002
4	LipidsIBA 07/2016 - 03/2003
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 01/2011
3	Insulin (Novolin)FDA Link 01/2018 - 01/2009
3	CytokinesIBA 04/2017 - 07/2013
3	Messenger RNA (mRNA)IBA 08/2013 - 01/2012
3	CarnosineIBA 01/2011 - 08/2005
2	IntegrinsIBA 11/2023 - 12/2005
2	Neuroprotective AgentsIBA 11/2023 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 01/2016
2	Glucosamine (Dona)IBA 01/2022 - 12/2021
2	EnzymesIBA 01/2022 - 03/2003
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2009
2	Epoxide HydrolasesIBA 12/2019 - 12/2017
2	DiglyceridesIBA 10/2019 - 03/2003
2	aminoacyl-histidine dipeptidaseIBA 01/2019 - 08/2005
2	LinagliptinIBA 11/2018 - 01/2016
2	Erythropoietin FDA Link 04/2017 - 01/2014
2	CholesterolIBA 01/2017 - 11/2012
2	Adenosine Triphosphate (ATP)IBA 07/2016 - 11/2012
2	Oxygen (Dioxygen)IBA 01/2016 - 01/2009
2	Angiopoietin-1IBA 06/2014 - 02/2006
2	AdiponectinIBA 01/2014 - 09/2013
2	LDL CholesterolIBA 01/2014 - 11/2012
2	Peptides (Polypeptides)IBA 01/2014 - 08/2004
2	AdipokinesIBA 01/2014 - 09/2013
2	benphothiamine (benfotiamine)IBA 05/2011 - 03/2003
2	SolutionsIBA 01/2009 - 03/2006
2	alpha-DefensinsIBA 12/2005 - 08/2004
1	Transforming Growth Factor-beta Type I ReceptorIBA 11/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2023
1	lixisenatideIBA 11/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023
1	FlavonoidsIBA 04/2022
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2022
1	GlucokinaseIBA 01/2022
1	asparaginylendopeptidase (legumain)IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	phosphatidylethanolamineIBA 01/2022
1	Xedar ReceptorIBA 01/2022
1	Liposomes (Liposome)IBA 01/2021
1	IronIBA 01/2021
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 01/2021

Therapy/Procedure

7	Therapeutics 01/2020 - 03/2002
2	Bariatric Surgery 04/2016 - 11/2012
2	Lasers (Laser) 03/2016 - 03/2002
2	Light Coagulation 03/2016 - 03/2002
2	Glycemic Control 01/2016 - 04/2006